Related Experiment Video

Updated: Feb 11, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

15.2K

Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas

Jun Gong1, Jessica Yan2, Charles Forscher3

  • 1Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA.

Drug Design, Development and Therapy
|April 20, 2018
PubMed

Insights

Aldoxorubicin, a novel doxorubicin prodrug, shows promise for treating relapsed or refractory soft tissue sarcomas (STS). Clinical trials indicate efficacy with reduced cardiac toxicity, addressing a significant unmet need in advanced STS treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Development

Background:

  • Prognosis for relapsed or refractory soft tissue sarcomas (STS) remains poor despite existing therapies.
  • There is a critical need for novel therapeutic agents to improve outcomes in advanced STS.
  • Aldoxorubicin is a prodrug designed for targeted delivery of doxorubicin.

Purpose of the Study:

  • To review the clinical development of aldoxorubicin in soft tissue sarcomas.
  • To highlight pharmacokinetic and efficacy data from clinical trials.
  • To discuss future research directions for aldoxorubicin in STS.

Main Methods:

  • Review of Phase I, II, and III clinical trial data for aldoxorubicin in advanced or metastatic STS.
  • Analysis of pharmacokinetics and efficacy.
  • Examination of safety profile, particularly cardiac toxicity.

Main Results:

  • Aldoxorubicin demonstrates evidence of efficacy in clinical studies of STS.
  • The drug exhibits mitigated cardiac toxicity compared to traditional doxorubicin.
  • Data from multiple phases of clinical trials support its potential in advanced STS.

Conclusions:

  • Aldoxorubicin represents a promising antitumor agent for STS.
  • Its targeted delivery mechanism offers potential for improved efficacy and safety.
  • Further investigation is warranted to establish its role in STS treatment paradigms.
Keywords:
albumin conjugatealdoxorubicincardiotoxicityclinical trialspharmacokineticssoft tissue sarcomas

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.3K
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.5K

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.0K
Conjugated Proteins02:50

Conjugated Proteins

3.2K
Conjugation01:19

Conjugation

Conjugation is a form of horizontal gene transfer that primarily occurs in bacteria and some archaea, promoting genetic diversity and adaptation. Bacteria can acquire resistance genes through conjugative plasmids, allowing them to survive antibiotic treatments that would otherwise be lethal. This process involves direct contact between cells through specialized structures such as the sex pilus and is mediated by conjugative plasmids, including the F (fertility) factor.Conjugation requires...
2.4K
Mechanism of Conjugation01:19

Mechanism of Conjugation

Bacterial conjugation is a mechanism of horizontal gene transfer that enables the exchange of genetic material between bacterial cells through direct contact. This process is facilitated by a donor cell carrying a conjugative plasmid, which encodes genes necessary for pilus formation, DNA replication, and transfer. The conjugative plasmid plays a central role in initiating and executing the transfer of genetic material.The tra region of the conjugative plasmid encodes proteins responsible for...
1.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Relative Strengths of Conjugate Acid-Base Pairs02:29

Relative Strengths of Conjugate Acid-Base Pairs

Brønsted-Lowry acid-base chemistry is the transfer of protons; thus, logic suggests a relation between the relative strengths of conjugate acid-base pairs. The strength of an acid or base is quantified in its ionization constant, Ka or Kb, which represents the extent of the acid or base ionization reaction. For the conjugate acid-base pair HA / A−, the ionization equilibrium equations and ionization constant expressions are
52.7K